60 DEGREES PHARMACEUTICALS, INC. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Washington, DC
SEC filing record 1 source field available
Fiscal year end
31 December
60 DEGREES PHARMACEUTICALS, INC. has filed 217 SEC EDGAR filings since 18 Oct 2022

SEC filing history

Showing 126-150 of 217 matching filings.

Per page
25
Current page
6
4

4 filing

Filing date
21 May 2024
Reporting date
21 Nov 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
21 May 2024
Reporting date
31 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
21 May 2024
Reporting date
21 Nov 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
21 May 2024
Reporting date
31 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-41719

QUARTERLY REPORT

Filing date
15 May 2024
Reporting date
31 Mar 2024
Next action
Verify source filing
SC 13G/A File 005-94258

SC 13G/A

Filing date
07 May 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 001-41719

PRELIMINARY PROXY STATEMENT

Filing date
03 May 2024
Reporting date
03 May 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-41719

CURRENT REPORT

Filing date
02 May 2024
Reporting date
26 Apr 2024
Next action
Verify source filing
4

FORM 4

Filing date
03 Apr 2024
Reporting date
28 Jul 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 001-41719

ANNUAL REPORT

Filing date
01 Apr 2024
Reporting date
31 Dec 2023
Next action
Verify source filing
8-K File 001-41719

CURRENT REPORT

Filing date
28 Feb 2024
Reporting date
27 Feb 2024
Next action
Verify source filing
8-K File 001-41719

CURRENT REPORT

Filing date
20 Feb 2024
Reporting date
13 Feb 2024
Next action
Verify source filing
4

4 filing

Filing date
02 Feb 2024
Reporting date
31 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
02 Feb 2024
Reporting date
31 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
424B4 File 333-276641

PROSPECTUS

Filing date
31 Jan 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-276641

EFFECT filing

Filing date
29 Jan 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
26 Jan 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
26 Jan 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
26 Jan 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
22 Jan 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
22 Jan 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-41719

CURRENT REPORT

Filing date
22 Jan 2024
Reporting date
22 Jan 2024
Next action
Verify source filing
S-1 File 333-276641

REGISTRATION STATEMENT

Filing date
22 Jan 2024
Reporting date
Not listed
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .